Booker H E
Adv Neurol. 1975;11:369-82.
Successful treatment of partial complex seizures (and the epilepsies in general) is a process of management over time and involves several factors. It starts with accurate and adequate diagnostic formulations. To this end the physician must be thoroughly familiar with the ictal manifestations of partial complex and other epilepsies as well as the clinical features of other transient but reversible episodes that might present difficulties in differential diagnosis. The diagnosis is based upon the history of a patient experiencing partial complex seizures, and the most important resource is a careful and detailed history of the ictal events and the circumstances under which they occur. Clinical observation and electrophysiologic monitoring of the patient during attacks, either spontaneous or induced, is the most powerful technique available in cases which present difficult diagnostic problems. In addition to recognition and proper classification of the seizures themselves, diagnosis and treatment of the cause of the seizures, particularly when it is an active disease, is of prime importance. Even after accurate diagnosis, the heterogenous nature of the population of patients with partial complex seizures is such that marked variation in response to treatment with antiepileptic drugs is to be anticipated. The use of these drugs must be individualized and based upon a thorough and working knowledge of their clinical pharmacology. The most frequent mistakes in our experience have been prescribing the drugs in too little doses or for too short a time. Less often the problem is overmedication. The best indicator of the effectiveness of the drugs is the clinical response of the individual patient, and in general each drug should be prescribed in increasing doses until either the seizures are controlled or unacceptable degrees of toxicity develop. The use of serum level determinations can be very helpful if not invaluable, particularly in identifying and understanding potential adverse effects of the drugs. Patient noncompliance in adhering to drug schedules is widespread, but usually can be detected by measuring serum levels. Even with the most efficient use of the drugs, however, some patients will be intractable, and elective surgical treatment should be considered. Finally, control of seizure occurrence alone is not necessarily adequate treatment, as many patients will have difficult psychosocial problems associated with their epilepsy. Treatment of such associated problems is necessary on its own merits, but occasionally can result in significant improvement in seizure control.
成功治疗部分性复杂性发作(以及一般的癫痫)是一个长期的管理过程,涉及多个因素。这一过程始于准确且充分的诊断。为此,医生必须全面熟悉部分性复杂性发作及其他癫痫的发作表现,以及其他可能在鉴别诊断中造成困难的短暂但可逆发作的临床特征。诊断基于患者经历部分性复杂性发作的病史,而最重要的信息来源是对发作事件及其发生时的情况进行仔细且详尽的病史询问。在发作期间,无论是自发发作还是诱发发作,对患者进行临床观察和电生理监测,是解决诊断难题时最有效的技术手段。除了识别发作本身并进行恰当分类外,对发作原因进行诊断和治疗,尤其是当病因是活动性疾病时,至关重要。即使经过准确诊断,部分性复杂性发作患者群体的异质性使得使用抗癫痫药物治疗后的反应存在显著差异。这些药物的使用必须个体化,并基于对其临床药理学深入且实用的了解。根据我们的经验,最常见的错误是药物剂量过小或用药时间过短。较少见的问题是用药过量。药物疗效的最佳指标是个体患者的临床反应,一般来说,每种药物都应逐渐增加剂量,直至发作得到控制或出现不可接受的毒性程度。血清水平测定如果不是至关重要的话,也会非常有帮助,特别是在识别和理解药物潜在的不良反应方面。患者不遵守药物治疗方案的情况很普遍,但通常可以通过测量血清水平来发现。然而,即使最有效地使用药物,仍有一些患者会难以控制发作,此时应考虑选择性手术治疗。最后,仅控制发作的发生不一定是充分的治疗,因为许多患者会有与癫痫相关的严重心理社会问题。对这些相关问题进行治疗本身就很有必要,但有时也会显著改善发作的控制情况。